跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 334 条关于
“Cempra”
全部
334
临床试验
302
药物
11
机构
9
资讯
12
10个月前
Edgewise Therapeutics Strengthens Board with Commercial Veteran Ahead of Becker Muscular Dystrophy Launch
去年
REMORA Trial: Integrating Symptom Tracking App into Rheumatoid Arthritis Care
21天前
Asieris Launches CEVIRA, World's First Non-Invasive Treatment for Precancerous Cervical Lesions
去年
Asieris Pharmaceuticals' Cevira (APL-1702) Shows Promise in HSIL Treatment: Phase III Subgroup Analysis
6个月前
EMA Accepts Marketing Authorization Application for Cevira, First-in-Class Photodynamic Therapy for Cervical Lesions
6个月前
BioDuro and Cenra Form Strategic Joint Venture to Strengthen Global API Manufacturing Network
去年
Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs
去年
Empagliflozin's Cardiorenal Benefits Persist One Year After Discontinuation: EMPA-KIDNEY Follow-Up
去年
Empagliflozin Demonstrates Cost-Effectiveness in Chronic Kidney Disease Treatment, EMPA-KIDNEY Analysis Shows
去年
EMPA-KIDNEY Trial: Empagliflozin Shows Sustained Cardiorenal Benefits in CKD Patients Post-Discontinuation
第 1 页,共 2 页
上一页
下一页